Literature DB >> 28062564

TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment.

Michael W Pickup1, Philip Owens1, Harold L Moses1.   

Abstract

The cellular and noncellular components surrounding the tumor cells influence many aspects of tumor progression. Transforming growth factor β (TGF-β), bone morphogenetic proteins (BMPs), and activins have been shown to regulate the phenotype and functions of the microenvironment and are attractive targets to attenuate protumorigenic microenvironmental changes. Given the pleiotropic nature of the cytokines involved, a full understanding of their effects on numerous cell types in many contexts is necessary for proper clinical intervention. In this review, we will explore the various effects of TGF-β, BMP, and activin signaling on stromal phenotypes known to associate with cancer progression. We will summarize these findings in the context of their tumor suppressive or promoting effects, as well as the molecular changes that these cytokines induce to influence stromal phenotypes.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28062564      PMCID: PMC5411701          DOI: 10.1101/cshperspect.a022285

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  26 in total

1.  Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer.

Authors:  Anne Serrao; Laura M Jenkins; Alexander A Chumanevich; Ben Horst; Jiaxin Liang; Michael L Gatza; Nam Y Lee; Igor B Roninson; Eugenia V Broude; Karthikeyan Mythreye
Journal:  Oncogene       Date:  2018-05-21       Impact factor: 9.867

2.  TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR.

Authors:  Ella Bhagyaraj; Nancy Ahuja; Sumit Kumar; Drishti Tiwari; Shalini Gupta; Ravikanth Nanduri; Pawan Gupta
Journal:  Cell Cycle       Date:  2019-11-18       Impact factor: 4.534

3.  A role for cell-autocrine interleukin-2 in regulatory T-cell homeostasis.

Authors:  Amanpreet Singh Chawla; Jasneet Kaur Khalsa; Atika Dhar; Suman Gupta; Danish Umar; Gopalakrishnan Aneeshkumar Arimbasseri; Vineeta Bal; Anna George; Satyajit Rath
Journal:  Immunology       Date:  2020-04-14       Impact factor: 7.397

Review 4.  Molecular mechanisms and clinical management of cancer bone metastasis.

Authors:  Manni Wang; Fan Xia; Yuquan Wei; Xiawei Wei
Journal:  Bone Res       Date:  2020-07-29       Impact factor: 13.567

5.  Membrane targeting of inhibitory Smads through palmitoylation controls TGF-β/BMP signaling.

Authors:  Wenqing Li; Weini Li; Lihui Zou; Shanming Ji; Chaoyi Li; Kehui Liu; Guoqiang Zhang; Qinmiao Sun; Fei Xiao; Dahua Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-27       Impact factor: 11.205

Review 6.  EMT and inflammation: inseparable actors of cancer progression.

Authors:  Meggy Suarez-Carmona; Julien Lesage; Didier Cataldo; Christine Gilles
Journal:  Mol Oncol       Date:  2017-06-26       Impact factor: 6.603

Review 7.  Recent advances in understanding contextual TGFβ signaling.

Authors:  Arshad Ayyaz; Liliana Attisano; Jeffrey L Wrana
Journal:  F1000Res       Date:  2017-05-26

Review 8.  Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts.

Authors:  Sergio Lamprecht; Ina Sigal-Batikoff; Shraga Shany; Naim Abu-Freha; Eduard Ling; George J Delinasios; Keren Moyal-Atias; John G Delinasios; Alexander Fich
Journal:  Cancers (Basel)       Date:  2018-02-27       Impact factor: 6.639

Review 9.  TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer.

Authors:  Laia Caja; Francesco Dituri; Serena Mancarella; Daniel Caballero-Diaz; Aristidis Moustakas; Gianluigi Giannelli; Isabel Fabregat
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

Review 10.  Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment.

Authors:  Franck Verrecchia; Françoise Rédini
Journal:  Front Oncol       Date:  2018-04-30       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.